BCG vaccine trial update, with Professor Andreas Diacon

Stellenbosch University Professor Andreas Diacon is the force behind a 500-person clinical trial aimed at determining whether the BCG vaccines many South Africans got as children to protect against TB are indeed a shield against Covid-19. The trial involves revaccination of BCG that’s been universally applied in South Africa since 1973. Numerous reports have pointed out a correlation between infection rates for countries where BCG is universally administered as being far lower than in those countries like the USA, Italy and Belgium where it was never used. Learn more about your ad choices. Visit megaphone.fm/adchoices